Humacyte
Price & Volume
Stats
See more52W Range | $1.15-$6.77 |
Market Cap | $249M |
Shares Short | 27M |
Financials
See moreRevenue (12 Mos) | $818,000 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$80.5M |
Diluted EPS | -$0.47 |
News
See moreYahoo Finance • 3 days ago
Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025
Yahoo Finance • last month
Humacyte rises after positive data from humanitarian study of Symvess
Yahoo Finance • last month
Humacyte Announces Publication of Long-Term Results for Ukrainian Patients Treated in Real-World Combat Setting with Symvess™
Yahoo Finance • 2 months ago
Humacyte Plans To File IND For Coronary Tissue Engineered Vessel In Q4
About
CEO | Dr. Laura E. Niklason M.D., Ph.D. |
CFO | Mr. Dale A. Sander |
Address | 2525 East North Carolina Highway 54, Durham, NC, United States, 27713 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 218 |
